The forthcoming Symposium of MESAEP (Mediterranean Scientific Association of Environmental Protection) will be held in Rome, Italy in the beginning... ...
Project Advisory Board (PAB)
External experts recognised for their expertise in the field of the Project will be appointed to give advice the management Board on the project orientations and on all matters of importance relating to further project planning and implementation. The Project Advisory Board is a scientific evaluation consultative body. The members of PAB comprise key policy scientists and researchers whose on-going input and commitment to HEALS would be especially valuable. At this time the advisory board is proposed to be composed by the following individuals:
- Dr. Marco Martuzzi, WHO, European Centre for Environment and Health (ECEH) Germany, Chair
- Prof. Peter Part, European Environment Agency and Joint Research Centre, Denmark, Co-chair
- Dr. Stella Kanna-Michaelidou, National Committee on Environment and Children’s Health and European Commissions’ Scientific Committee on Health and Environmental Risks, EFSA Management Board, Cyprus
- Dr. Luciana Sinisi, Istituto Superiore per la Protezione e la Ricerca Ambientale (I.S.P.R.A.), Italy
- Prof. Kirk Smith, University of California at Berkeley, USA
- Dr. Tina Bahadori, Director, Chemical Safety and Sustainability research program, US EPA, USA
- Dr. David Balshaw, Center for Risk and Integrated Sciences, NIEHS, USA
- Prof. Andreas Baccarelli, Harvard University, USA
- Dr Marike Kolossa, UBA, Germany
- Prof. Steve Montefort, Department of Medicine, Mater Dei Hospital and University of Malta, Malta.
Ethical Advisory Board (EAB)
An Ethical Advisory Board (EAB) will be established in the early stage of the project to monitor and review all issues with respect to observation of ethical principles in humans. The Ethical Advisory Board will also organize ethics courses on a regular basis at annual meetings. The EAB will be composed of experts on Ethical Issues who are also expert on the type of experiments on human and patients to be performed in HEALS and with detailed knowledge of ethical policies. This could include members ISEE Ethics Committee and of the EU Groups on Ethics in Sciences and New technologies (EGE). Experts who make up the committee represent the various interests involved, including human research expertise, data protection, biobank and database specialties. The EAB is in charge of monitoring the fulfilment of ethical issues and requirements especially during patient recruitment and follow-up and during the system validation phase.